Literature DB >> 3792776

Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B. Chylomicron retention disease.

C C Roy, E Levy, P H Green, A Sniderman, J Letarte, J P Buts, J Orquin, P Brochu, A M Weber, C L Morin, Y Marcel, R J Deckelbaum.   

Abstract

Eight infants presented with a malabsorption syndrome, normal fasting triglycerides, hypocholesterolemia (64.3 +/- 10.0 mg/dl), and deficiency of vitamins A and E. Plasma low-density lipoprotein, apolipoprotein B, and apolipoprotein A-I were decreased. After a fatty meal, plasma triglycerides did not increase and chylomicrons could not be identified. Lipoprotein composition was characterized by normal apoproteins, high phospholipids, and low cholesterol. Increased triglycerides were present in low-density lipoproteins. Immunoperoxidase localization of apolipoprotein B on fasting biopsy specimens showed increased staining of the lipid-laden intestinal epithelial cells compared to normals. On electron microscopy after a fat load, the enterocytes contained large numbers of fat particles vesiculating the endoplasmic reticulum. These particles, morphologically similar to chylomicrons, were also present as aggregates of well-individualized lipid droplets within dilated vesicles in the Golgi zone, but were not seen in the intercellular spaces and lacteals. This recessively transmitted condition differs from abetalipoproteinemia and from the homozygous form of hypobetalipoproteinemia and may be caused by a defect in the final assembly of chylomicrons or in the mechanism of their exocytosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3792776     DOI: 10.1016/0016-5085(87)90133-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

1.  Phosphorylation of Sar1b protein releases liver fatty acid-binding protein from multiprotein complex in intestinal cytosol enabling it to bind to endoplasmic reticulum (ER) and bud the pre-chylomicron transport vesicle.

Authors:  Shahzad Siddiqi; Charles M Mansbach
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

2.  A genetic model for absent chylomicron formation: mice producing apolipoprotein B in the liver, but not in the intestine.

Authors:  S G Young; C M Cham; R E Pitas; B J Burri; A Connolly; L Flynn; A S Pappu; J S Wong; R L Hamilton; R V Farese
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

3.  Histochemical abnormalities in liver and jejunal biopsies from a case of cholesterol ester storage disease.

Authors:  A Lageron; J Polonovski
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

4.  Increased expression of apolipoprotein genes accompanies differentiation in the intestinal cell line Caco-2.

Authors:  S R Reisher; T E Hughes; J M Ordovas; E J Schaefer; S I Feinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

5.  Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease.

Authors:  Charlotte Cuerq; Emilie Henin; Lioara Restier; Emilie Blond; Jocelyne Drai; Christophe Marçais; Mathilde Di Filippo; Christian Laveille; Marie-Caroline Michalski; Pierre Poinsot; Cyrielle Caussy; Agnès Sassolas; Philippe Moulin; Emmanuelle Reboul; Sybil Charriere; Emile Levy; Alain Lachaux; Noël Peretti
Journal:  J Lipid Res       Date:  2018-07-18       Impact factor: 5.922

6.  Animal model of Sar1b deficiency presents lipid absorption deficits similar to Anderson disease.

Authors:  Daniel S Levic; J R Minkel; Wen-Der Wang; Witold M Rybski; David B Melville; Ela W Knapik
Journal:  J Mol Med (Berl)       Date:  2015-01-07       Impact factor: 4.599

Review 7.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

Review 8.  Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers.

Authors:  Noel Peretti; Agnès Sassolas; Claude C Roy; Colette Deslandres; Mathilde Charcosset; Justine Castagnetti; Laurence Pugnet-Chardon; Philippe Moulin; Sylvie Labarge; Lise Bouthillier; Alain Lachaux; Emile Levy
Journal:  Orphanet J Rare Dis       Date:  2010-09-29       Impact factor: 4.123

9.  Mice lacking phosphatidylinositol transfer protein-alpha exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia.

Authors:  James G Alb; Jorge D Cortese; Scott E Phillips; Roger L Albin; Tim R Nagy; Bruce A Hamilton; Vytas A Bankaitis
Journal:  J Biol Chem       Date:  2003-06-04       Impact factor: 5.157

10.  Anderson's disease: genetic exclusion of the apolipoprotein-B gene in two families.

Authors:  M Pessah; P Benlian; I Beucler; N Loux; J Schmitz; C Junien; R Infante
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.